Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)
China · Delayed Price · Currency is CNY 20.28
-0.53 (-2.55%)
Aug 31, 2026, 3:04 PM CST
SHE:002773 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 4,311 | 4,585 | 4,453 | 3,957 | 3,389 | 3,605 |
Revenue Growth | -6.54% | 2.97% | 12.51% | 16.77% | -6.00% | 9.40% |
Gross Profit Gross Profit Growth | 3,840 | 4,118 | 3,983 | 3,519 | 2,997 | 3,250 |
Operating Income Operating Income Growth | 1,057 | 1,257 | 1,232 | 1,101 | 864.46 | 407 |
Net Income Net Income Growth | 998.01 | 1,163 | 1,191 | 1,045 | 896.67 | 421.08 |
Earnings Per Share EPS Growth | 1.08 | 1.26 | 1.30 | 1.14 | 0.98 | 0.46 |
EPS Growth | -19.42% | -3.08% | 14.04% | 16.33% | 113.04% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Pharmaceutical Manufacturing Pharmaceutical Manufacturing Growth | 4,308 | 4,583 | 4,451 | 3,957 | 3,388 | 3,605 |
Unallocated Other Business Unallocated Other Business Growth | 2.21 | 1.88 | 1.49 | 0.63 | 0.64 | 0.19 |
Total Total Growth | 4,311 | 4,585 | 4,453 | 3,957 | 3,389 | 3,605 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 6,341 | 6,435 | 5,690 | 4,702 | 3,685 | 3,139 |
Total Debt Total Debt Growth | 2.15 | 3.51 | 5.2 | 2.01 | 4.87 | 7 |
Net Cash (Debt) Net Cash Growth | 6,339 | 6,432 | 5,684 | 4,700 | 3,681 | 3,132 |
Net Cash Growth | 5.74% | 13.15% | 20.94% | 27.70% | 17.52% | -5.88% |
Net Cash Per Share Net Cash Per Share Growth | 6.86 | 6.97 | 6.20 | 5.13 | 4.02 | 3.42 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 1,128 | 1,504 | 1,412 | 1,218 | 925.15 | 494.11 |
Capital Expenditures CapEx Growth | -332.71 | -262.48 | -159.39 | -138.87 | -355.21 | -569.42 |
Free Cash Flow Free Cash Flow Growth | 794.93 | 1,241 | 1,252 | 1,080 | 569.95 | -75.3 |
Free Cash Flow Growth | -41.74% | -0.90% | 16.02% | 89.41% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 89.09% | 89.81% | 89.46% | 88.91% | 88.44% | 90.14% |
Operating Margin | 24.53% | 27.42% | 27.68% | 27.81% | 25.51% | 11.29% |
Pretax Margin | 27.00% | 29.58% | 30.38% | 31.18% | 30.40% | 10.91% |
Profit Margin | 23.15% | 25.36% | 26.75% | 26.40% | 26.46% | 11.68% |
FCF Margin | 18.44% | 27.07% | 28.13% | 27.28% | 16.82% | -2.09% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.700 | 0.700 | 0.600 | 0.380 | 0.150 | 0.100 |
Dividend Per Share Growth | 16.67% | 16.67% | 57.89% | 153.33% | 50.00% | 0% |
Dividend Yield | 3.17% | 2.42% | 3.23% | 2.21% | 1.03% | 0.53% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 19.27 | 23.74 | 15.13 | 16.23 | 16.09 | 44.44 |
Forward PE | - | 20.81 | 13.38 | 15.30 | 12.75 | 17.93 |
P/FCF Ratio | 24.12 | 22.25 | 14.39 | 15.71 | 25.31 | - |
PS Ratio | 4.45 | 6.02 | 4.05 | 4.28 | 4.26 | 5.19 |